He highlighted one recent potentially practice-changing study in which University of Pittsburgh investigators tested 224 MSM and 175 women with a history of receptive anal intercourse for genitourinary, rectal, and oral gonorrhea
Approximately 1 million people 81% of the New Zealand population younger than 20 years - received almost 3 million doses of the OMV meningococcal B vaccine (MeNZB) in a 2-year mass immunization program during the outbreak, allowing the investigators to compare the rate of gonorrhea
between vaccinated and unvaccinated people.
In collaboration with CARB-X, Debiopharm will utilise its state-of-the-art Fabiotics platform to develop novel therapeutics to combat drug-resistant gonorrhea
The bacteria that cause gonorrhea
are particularly smart.
Nevertheless, about 80 percent of gonorrhea
infections in the United States could be treated with ciprofloxacin.
We think pharyngeal gonorrhea
is now the most important factor in this continuing epidemic," according to Dr.
In a Seattle clinic, the proportion of MSM with pharyngeal gonorrhea
All cases of gonorrhea
reported in Utah during 2009-2014 were included in the analysis.
Kirkcaldy of the Centers for Disease Control and Prevention's Division of STD Prevention and his colleagues suggest that treatment-resistant gonorrhea
is a challenge that clinicians will likely continue to confront (JAMA.
Rapid tests for the diagnosis of gonorrhea
- test kits for male patients.
The report provides a snapshot of the global therapeutic landscape of Gonorrhea
8% of participants had knowledge that PID is a complication of Gonorrhea
ATLANTA -- Prenatal screening for chlamydia and gonorrhea
is commonly performed in conjunction with Pap testing, which results in low screening rates among those who don't undergo Pap testing, a retrospective cohort study showed.
The problem of antibiotic-resistant infections has garnered increasing attention in recent years, and in the reproductive health arena, that threat has taken the form of antibiotic-resistant strains of gonorrhea
Ask women who are at risk for sexually transmitted infections (STIs) to self-swab for chlamydia and gonorrhea
testing; self-collection of vulvovaginal swabs with nucleic acid amplification testing (NAAT) has excellent sensitivity in women with and without symptoms.